|
MLL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.055600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.462410E-02 |
| Normal-vs-Stage2 |
1.223610E-01 |
| Normal-vs-Stage3 |
3.976200E-01 |
| Normal-vs-Stage4 |
2.841400E-01 |
| Stage1-vs-Stage2 |
7.833400E-01 |
| Stage1-vs-Stage3 |
2.226200E-02 |
| Stage1-vs-Stage4 |
1.157230E-01 |
| Stage2-vs-Stage3 |
2.360600E-01 |
| Stage2-vs-Stage4 |
3.284400E-01 |
| Stage3-vs-Stage4 |
7.059800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.124300E-02 |
| Normal-vs-AfricanAmerican |
1.122040E-01 |
| Normal-vs-Asian |
8.272200E-02 |
| Caucasian-vs-AfricanAmerican |
8.971200E-01 |
| Caucasian-vs-Asian |
3.686600E-01 |
| AfricanAmerican-vs-Asian |
4.044000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.128200E-02 |
| Normal-vs-Female |
2.378000E-02 |
| Male-vs-Female |
5.611800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.565600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.415150E-03 |
| Normal-vs-Age(61-80Yrs) |
3.476000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.477200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.699200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.963020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.573040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.242460E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.380200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.304400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.770600E-04 |
| Normal-vs-Grade 2 |
1.338030E-03 |
| Normal-vs-Grade 3 |
4.234600E-01 |
| Normal-vs-Grade 4 |
4.215800E-01 |
| Grade 1-vs-Grade 2 |
2.301500E-02 |
| Grade 1-vs-Grade 3 |
1.389800E-04 |
| Grade 1-vs-Grade 4 |
1.958910E-03 |
| Grade 2-vs-Grade 3 |
6.158800E-04 |
| Grade 2-vs-Grade 4 |
2.081700E-02 |
| Grade 3-vs-Grade 4 |
7.985600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.300620E-03 |
| Normal-vs-ccB subtype |
6.224800E-01 |
| ccA subtype-vs-ccB subtype |
1.981410E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.740230E-01 |
| Normal-vs-N1 |
5.514800E-01 |
| N0-vs-N1 |
8.778400E-01 |
|
|
